The Fathallah Lab is focused on the molecular biology of malignant gliomas. Dr. Fathallah's goal is to understand glioma motility and invasion and devise therapeutic methods.
Dr. Goldberg is an Associate Professor of Neurology. His laboratory is focused on identifying the mechanisms of neuronal degeneration in Parkinson's disease and investigating the roles of mitochondrial dysfunction, oxidative stress and genetic mutations in Parkin, DJ-1, PINK1, alpha-synuclein and LRRK2 that cause inherited forms of Parkinson’s disease
Dr. Gray's laboratory focuses on Huntington’s disease, a rare and fatal genetic degenerative disorder. Her goal is to identify and understand mechanisms that contribute to Huntington’s disease pathology.
Dr. Herskowitz is an Assistant Professor of Neurology. His laboratory is focused on Alzheimer's disease and the development of novel therapeutic strategies to delay or prevent disease onset.
The King Lab is focused on mechanisms of growth factor mRNA stabilization in malignant gliomas and amyotrophic lateral sclerosis (ALS). Dr. King is also interested in molecular signatures of ALS in skeletal muscle. His long term goals are to identify potential therapeutic targets and to characterize biomarkers that may help in diagnosis and clinical monitoring.
The Limdi Lab's primary research focus is to elucidate genetic and environmental determinants of drug response, specifically those that are associated with toxicity and lack of efficacy. Her goal is to identify genetic and environmental predictors of anticoagulant and antiplatelet response and use this information to individualize therapy.
The Nabors Lab studies the role of post-transcriptional regulation of gene expression in primary brain cancers. The lab is focused on RNA binding proteins and their ability to regulate cell growth, proliferation, and invasion.
Dr. Payami is a Professor in Neurology. Her laboratory is focused on the prevention and treatment of Parkinson's disease and in particular the genes that interact with environmental risk factors. The goal is to predict who is at risk and what they should avoid and further personalize individual treatment for maximum benefit.
Dr. Roberson’s primary interest is age-related memory disorders and neurodegenerative disease, including Alzheimer's disease and frontotemporal dementia.
Dr. Standaert's lab is interested in the pharmacology and neurochemistry of the basal ganglia and the mechanisms of Parkinson's disease and other conditions which produce abnormalities of movement.
The Ubogu Lab, the Neuromuscular Immunopathology Research Laboratory, is interested in the molecular biology and physiology of the human blood-nerve barrier, as well as mechanisms of leukocyte trafficking into the peripheral nervous system in health and in immune-mediated disorders such as Guillain-Barre-syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, vasculitic neuropathy and neuropathies associated with human immunodeficiency virus infection.
The West Lab focuses on discovering the biochemical and genetic basis of neurological disorders such as Parkinson’s disease and autism spectrum disorders.
The Yacoubian Lab is focused on understanding the pathophysiology of Parkinson’s disease with the long-term goal of developing neuroprotective therapies.